Step Up For Guide Dogs This Winter: Join The PAWGUST Challenge
Whether you're walking solo or side-by-side with your dog, PAWGUST invites you to step outside every day in August and help raise vital funds for Blind Low Vision NZ Guide Dogs. Participants commit to walking or running a set distance while gathering sponsorship from friends, whānau and local supporters.
All funds raised support the breeding, raising, and training of guide dogs. Guide Dogs give people who are blind or have low vision greater freedom and independence.
When Michele Jackson from Devonport and her guide dog Sasha signed up for their first PAWGUST last year, Michele saw it as a great opportunity to get fit while supporting an incredible cause.
'I'd love to say I joined purely to raise money, and it's definitely an incredible cause, but I also saw it as a great way to get fit,' says Michele.
Michele was born with cataracts, which caused the majority of her vision impairment early in life. At age 13, glaucoma set in and took the remaining sight in her right eye, leaving her with a small amount of tunnel vision in her left.
'Having sponsors kept me motivated,' says Michele. 'Every time I thought about skipping a walk, I remembered the people who had donated, and it got me moving.'
With guide dog Sasha by her side, Michele not only reached her 60km target but exceeded it, clocking over 86km by the end of the month.
She and her friend also helped rally the community, hosting group walks on Takapuna Beach and turning an initial $2,000 fundraising goal into a last-minute sprint to raise $10,000.
Now, Michele is back for another PAWGUST, encouraging others to get involved. She adds, 'Start small. Set an achievable goal and grow it. And don't be afraid to ask people individually for support. That's what worked best for me.'
Why PAWGUST Matters
Unlike pet dogs, guide dogs work year-round navigating busy footpaths, e-scooters, road signs, and urban hazards to keep their blind or low vision handlers safe.
By taking part in PAWGUST, you're not just embracing daily movement, you're supporting a future where every New Zealander who needs a guide dog can have one.
'Every step taken in PAWGUST helps raise the funds we need to train more dogs like Sasha,' says Andrea Midgen, Chief Executive, Blind Low Vision NZ. 'These dogs give our clients freedom, confidence, and companionship.'
It's free to join PAWGUST, and you don't need a dog to take part. By gathering sponsors and getting moving, anyone can contribute to the $175,000 it takes to breed, train, and support a working guide dog throughout its career.
Unleash Your PAWtential and help create brighter futures with Blind Low Vision NZ.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NZ Herald
11 hours ago
- NZ Herald
Gisborne-based Mātai Institute secures $563k for meth and sports brain research
'With at least one in three Kiwis affected by a neurological condition in their lifetime, the work of these researchers is crucial to advancing healthcare and improving people's quality of life,' said the Neurological Foundation's head of research and acting chief executive, Dr Sarah Schonberger. Dr Sarah Schonberger is the head of research and acting chief executive of the Neurological Foundation. Schonberger acknowledged times were tough for Kiwi researchers. 'The need for innovation in healthcare and disease prevention is increasing at exactly the same time that investment is shrinking,' she said. 'We are so grateful that our generous supporters are able to make a real difference by helping fund bold, brilliant New Zealand research like Maryam and Josh's, which holds so much promise for important breakthroughs.' Schonberger said the international experts who reviewed the funding applications described them as timely and relevant. 'The research being done at Mātai is genuinely world-class. Kiwis are fortunate that we have such a great hub of excellence in Gisborne,' she said. Holdsworth said the institute was 'incredibly proud' to see Tayebi and McGeown recognised in the funding round. 'A huge thank you to the Neurological Foundation and its supporters for backing world-class science here in Tairāwhiti. 'We're also deeply grateful to the Hugh Green Foundation and the Fred Lewis Foundation – long-standing pillars of support, who, among others, have helped us reach this point in these projects.' The Neurological Foundation is the biggest non-government funder of neurological research in the country. McGeown received a further $3956 to attend the International Brain Injury Association (IBIA) World Congress. Mātai research projects receiving funding MRI biomarkers of brain recovery and treatment response in methamphetamine addiction: A longitudinal study Dr Maryam Tayebi Methamphetamine (meth) addiction is a huge problem affecting people's lives across New Zealand, with no effective medicines available yet. This project is investigating how meth addiction affects the brain and how it might heal during recovery. Using advanced MRI brain scans, researchers will track changes in the brains of people receiving treatment. The goal is to find signs that show who is likely to stay drug-free and who might relapse. By understanding how the brain recovers, doctors can better support people with meth addiction. This research could lead to more personalised treatments, making a big difference in how meth addiction is managed and helping more people successfully overcome addiction. Brain health in collision sports: Linking early-life changes to long-term clinical outcomes using multimodal neuroimaging Dr Joshua McGeown Many athletes in collision sports suffer repeated head impacts, which may lead to brain damage and higher risk for neurodegenerative disease. This damage is often 'invisible' because there is no noticeable bruising or swelling, and standard medical imaging doesn't show abnormalities. This research project uses clinical data and advanced brain scans from active and retired athletes to track how head impacts affect the brain over time. In collaboration with the Former Athlete Brain Health Research programme in Australia, this fellowship aims to understand whether early brain changes persist, progress, or recover. By studying active and retired athletes, the aim is to identify early signs of brain damage and develop better ways to prevent and treat injuries.
Otago Daily Times
a day ago
- Otago Daily Times
Ireland's wine label warning decision one NZ should follow
Health warnings are not required on New Zealand wine labels. Last week it was revealed that one of New Zealand's major wineries was putting cancer warning labels on wine bottles destined for Ireland, in order to be compliant in time for Ireland's new law that comes into force next year. This immediately prompts the question: if the people of Ireland will be warned about the cancer risk of alcohol consumption, why not New Zealanders? The decision by Ireland to mandate cancer warning labels is consistent with global health advice, including from the United States Surgeon-general. This reflects the strong evidence that alcohol is a cause of at least seven types of cancer including breast, bowel and oesophageal. New Zealanders have the right to know about the harms of alcohol, including the cancer risk. Despite this, the alcohol industry does not support warning labels on their products. But evidence shows that warning labels are an effective way to increase consumers' awareness and knowledge of alcohol-related harms. Previous research has found that only 18% of New Zealanders are able to name alcohol as a risk factor for cancer — despite alcohol being estimated to cause 6% of all cancer deaths in New Zealand. Warning labels on alcohol products could provide health benefits by prompting conversations with healthcare professionals. Let's imagine a 50-year-old woman who drinks regularly, perhaps a bottle of wine (about eight standard drinks a week). She sees this new warning label, which makes her stop and think. The next time she goes to see her GP, she mentions it. This could lead to many beneficial conversations. If her GP tells her that breast cancer represents 28% of all new cancer cases caused by alcohol in New Zealand, this may be the nudge she needs to go and have her mammogram, which she has been putting off. Or they could discuss things she can do to lower her cancer risk, including reducing her alcohol consumption. They might also talk about nutrition, physical activity and sun exposure. She decides to make some changes, as her first grandchild is on the way and she wants to stay healthy. Or her doctor could talk to her about alcohol's link to bowel cancer, which finally makes her raise the changes to her bowel habits she has been troubled by for over a year, but too embarrassed to ask about. These are hypothetical scenarios, but it is easy to imagine how something as simple as a warning label could have positive flow-on effects. Our scenario is consistent with research; a 2023 review found that alcohol warning labels are effective at prompting discussion and raising awareness of alcohol-related harms. Perhaps that's why 66% of New Zealanders already support a mandatory cancer warning label on alcohol? When talking about public health interventions for alcohol, we often hear industry pushback to this from a framing of "personal choice". But we think this is missing an important concept — the idea of making an informed choice. If you use a health service in New Zealand you are protected under a Code of Rights, where you have the "right to be fully informed" and then the "right to make an informed choice and give informed consent". This means you must be given appropriate and accurate information to help you make a choice. Tobacco labels must depict the health consequences of smoking to support people buying them to make an informed choice. Indeed, the first two criteria for making an informed choice relating to smoking are that 1) people should be aware of the health risks, and 2) the specific diseases caused by smoking. Key to "informed choice" is the provision of accurate information. The alcohol industry should not be allowed to block New Zealand consumers from being informed of the cancer risk of their products. We urge the New Zealand government to follow Ireland's pioneering lead and mandate cancer warning labels on alcohol products. This needs to occur alongside other evidence-based interventions that the World Health Organization recommends. This includes reducing the number of places that can sell alcohol, reducing trading hours, making it less affordable (by increasing excise tax) and restricting alcohol marketing. Cancer warning labels are only one of the actions needed to reduce the huge burden of alcohol-related harm in our communities. But they are a simple solution, straightforward to implement and a positive step in the right direction. By doing so, the government would be helping to create an environment that supports free and informed choice. — Newsroom • Dr Rose Crossin is a senior lecturer in the Department of Population Health, University of Otago (Christchurch); Emma Shields is in the advocacy and public affairs team at the Cancer Society of New Zealand.
Scoop
a day ago
- Scoop
Hato Hone St John And MAS Join Forces To Empower Kiwis With Life-Saving Skills
Aotearoa, New Zealand - Hato Hone St John is proud to announce a new partnership with MAS (Medical Assurance Society), who will serve as the principal sponsor of their 3 Steps for Life programme - a nationwide initiative that teaches New Zealanders how to respond confidently and effectively to cardiac arrest emergencies. With more than 2,000 cardiac arrests occurring in across New Zealand every year, the need for public awareness and action is urgent. The 3 Steps for Life programme provides simple, life-saving training: Call 111 for an ambulance, start CPR, and use an AED. 'This partnership is a game-changer,' says Jacci Tatnell, National Manager Community Education at Hato Hone St John. 'With MAS's support, we're expanding our reach across the motu, giving more people the tools and confidence to act when every second counts. Together, we're building a stronger, more resilient Aotearoa.' Advertisement - scroll to continue reading The three-year collaboration will enable Hato Hone St John to deliver more training sessions, reach underserved communities, and build on the success of campaigns like Shocktober and their Light the Way Annual Appeal. MAS, a New Zealand-owned mutual insurer and investment provider, shares Hato Hone St John's deep commitment to community wellbeing. Their support goes beyond sponsorship — MAS will also offer 3 Steps for Life training to their own staff, helping grow the number of trained responders in the community. 'We're honoured to support a programme that empowers New Zealanders with essential life-saving skills,' says Matt Harvey, MAS Chief Distribution and Marketing Officer. 'This partnership reflects our broader commitment to the health and resilience of our communities. It's about making a real difference — together.' MAS has a long history of supporting health-focused initiatives through their MAS Foundation, including projects that promote oral health and wellbeing in diverse communities. Their backing of 3 Steps for Life is a powerful extension of their mission to help New Zealanders thrive - physically, financially, and emotionally. Thanks to MAS's support, Hato Hone St John is poised to make an even greater impact - helping more Kiwis learn the precious skill of how to help save a life.
